IND Exempt Trials No Longer “Deemed” Covered By Medicare, CMS Says
Executive Summary
Clinical trials that are exempt from FDA's investigational new drug process would no longer automatically qualify for Medicare coverage under CMS' proposed Clinical Research Policy
You may also be interested in...
FDA Coffers Fill With Funds, But No Money For Reagan-Udall Or Lab Closures
FDA enters 2008 with the financial wherewithal to go full speed ahead in hiring and establishing the safety programs authorized by the FDA Amendments Act, following President Bush's signing of an omnibus fiscal 2008 appropriations package on Dec. 26
FDA Coffers Fill With Funds, But No Money For Reagan-Udall Or Lab Closures
FDA enters 2008 with the financial wherewithal to go full speed ahead in hiring and establishing the safety programs authorized by the FDA Amendments Act, following President Bush's signing of an omnibus fiscal 2008 appropriations package on Dec. 26
Medicare Clinical Research Policy Revisions Will Be Revisited, CMS Says
CMS plans to issue a new proposal to revise its Medicare clinical research policy that builds upon "extensive" public comments received to date